# To Evaluate Safety and Effectiveness of RovatitanTab.

> **NCT04398771** · — · UNKNOWN · sponsor: **LG Chem** · enrollment: 1000 (estimated)

## Conditions studied

- Hypertension
- Hyperlipidemias

## Interventions

- **DRUG:** Rosuvastatin/Valsartan

## Key facts

- **NCT ID:** NCT04398771
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04398771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04398771, "To Evaluate Safety and Effectiveness of RovatitanTab.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04398771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*